April 26, 2018 9:26 PM ET


Company Overview of Delinia, Inc.

Company Overview

Delinia, Inc., a biotechnology company, focuses on developing novel therapeutics for the treatment of autoimmune diseases. Its lead program is a molecule that potentiates and expands regulatory T cells (Tregs), which are critical to maintaining self-tolerance and immune system homeostasis. The company was incorporated in 2014 and is based in San Francisco, California. Delinia, Inc. As of February 3, 2017, Delinia, Inc. operates as a subsidiary of Celgene Corporation.

953 Indiana Street

San Francisco, CA 94107

United States

Founded in 2014

Key Executives for Delinia, Inc.

Co-Founder and Chief Scientific Officer
Co-Founder and Chair of Scientific Advisory Board
Senior Vice President of Preclinical and Early Clinical Development
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Delinia, Inc., please visit www.deliniabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.